Related Experiment Videos
Immunopathogenesis of dilated cardiomyopathies
1Department of Cardiological Sciences, St. George's Hospital Medical School, London, UK.
Current Opinion in Cardiology
|May 1, 1995
Summary
Idiopathic dilated cardiomyopathy may involve immune system responses, with myosin acting as a potential antigen. Researchers found cardiac autoantibodies in some patients, suggesting an autoimmune basis for this heart muscle disorder.
Area of Science:
- Cardiology
- Immunology
- Autoimmune Diseases
Background:
- Idiopathic dilated cardiomyopathy (IDC) is a chronic heart muscle disorder with unknown causes.
- Growing evidence suggests an immune system role in a subset of IDC patients.
- Myosin is increasingly recognized as a potential autoantigen in IDC.
Purpose of the Study:
- To investigate the role of immune pathogenesis in idiopathic dilated cardiomyopathy.
- To explore myosin as a potential antigen in the development of IDC.
- To identify cardiac-specific autoantibodies and immunogenic epitopes in IDC patients.
Main Methods:
- Review of experimental and clinical evidence.
- Analysis of autoantibody presence in patients and relatives.
- Identification of specific antigenic targets.
Main Results:
- Evidence supports an immune-mediated pathogenesis in a proportion of IDC cases.
- Cardiac- and disease-specific autoantibodies were detected in some patients and their relatives.
- Specific immunogenic epitopes related to myosin have been identified.
Conclusions:
- An autoimmune basis involving myosin is implicated in a subset of idiopathic dilated cardiomyopathy.
- Autoantibodies may serve as biomarkers for disease risk or presence.
- Further research into immune mechanisms could lead to new therapeutic strategies for IDC.